Skip to main content
Premium Trial:

Request an Annual Quote

Alpha Laboratories to Distribute AdvanDx's QuickFISH Test in UK

NEW YORK (GenomeWeb News) – AdvanDx recently announced the appointment of Alpha Laboratories to support the launch of AdvanDx's molecular QuickFISH test.

Under the terms of the deal, Alpha Lab has the exclusive rights to distribute the test in the UK. QuickFISH detects Staphylococcus aureus and/or coagulase-negative staphylococci and received 510(k) clearance from the US Food and Drug Administration in April. It was launched in the US and Europe in September.

The test uses AdvanDx's proprietary peptide nucleic acid technology to identify species of bacteria in 20 minutes directly from positive blood cultures. Pathogen identification can now be reported simultaneously with Gram stain results, the firm said.

The company, which has offices in Woburn, Mass. and Vedbaek, Denmark, said that additional QuickFISH assays are being developed for other microbial species and will be launched this year and in 2013.

Financial and other terms of the deal were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.